 | • レポートコード：MRC308GR11638 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のカルチノイド腫瘍症候群の治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のカルチノイド腫瘍症候群の治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– カルチノイド腫瘍症候群の治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
カルチノイド腫瘍症候群の治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・化学療法、生物学的療法、放射線療法
用途別セグメント
・病院、診療所、家庭
主要な市場プレーヤー
・Novartis AG、Teva Pharmaceutical Industries Ltd.、Mylan N.V.、Ipsen Biopharmaceuticals, Inc、Sun Pharmaceutical Industries Ltd、Amgen Inc.、Entrinsic Health Solutions, Inc.、Endo Pharmaceuticals Inc.、Sirtex SIR-Spheres Pty Ltd、BTG International Ltd
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、カルチノイド腫瘍症候群の治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルチノイド腫瘍症候群の治療メーカーの企業概要、2019年～2022年までのカルチノイド腫瘍症候群の治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルチノイド腫瘍症候群の治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別カルチノイド腫瘍症候群の治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのカルチノイド腫瘍症候群の治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのカルチノイド腫瘍症候群の治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびカルチノイド腫瘍症候群の治療の産業チェーンを掲載しています。
・第14、15章では、カルチノイド腫瘍症候群の治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– カルチノイド腫瘍症候群の治療の概要
– 種類別分析（2018年vs2022年vs2029年）：化学療法、生物学的療法、放射線療法
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、家庭
– 世界のカルチノイド腫瘍症候群の治療市場規模・予測
– 世界のカルチノイド腫瘍症候群の治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis AG、Teva Pharmaceutical Industries Ltd.、Mylan N.V.、Ipsen Biopharmaceuticals, Inc、Sun Pharmaceutical Industries Ltd、Amgen Inc.、Entrinsic Health Solutions, Inc.、Endo Pharmaceuticals Inc.、Sirtex SIR-Spheres Pty Ltd、BTG International Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：化学療法、生物学的療法、放射線療法
・用途別分析2018年-2029年：病院、診療所、家庭
・カルチノイド腫瘍症候群の治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルチノイド腫瘍症候群の治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルチノイド腫瘍症候群の治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルチノイド腫瘍症候群の治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・カルチノイド腫瘍症候群の治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Carcinoid Tumor Syndrome Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Chemotherapy
1.3.3 Biological Therapy
1.3.4 Radio Therapy
1.4 Market Analysis by Application
1.4.1 Overview: Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Home
1.5 Global Carcinoid Tumor Syndrome Treatment Market Size & Forecast
1.5.1 Global Carcinoid Tumor Syndrome Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Carcinoid Tumor Syndrome Treatment Sales Quantity (2018-2029)
1.5.3 Global Carcinoid Tumor Syndrome Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Carcinoid Tumor Syndrome Treatment Product and Services
2.1.4 Novartis AG Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Teva Pharmaceutical Industries Ltd.
2.2.1 Teva Pharmaceutical Industries Ltd. Details
2.2.2 Teva Pharmaceutical Industries Ltd. Major Business
2.2.3 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Product and Services
2.2.4 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.3 Mylan N.V.
2.3.1 Mylan N.V. Details
2.3.2 Mylan N.V. Major Business
2.3.3 Mylan N.V. Carcinoid Tumor Syndrome Treatment Product and Services
2.3.4 Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan N.V. Recent Developments/Updates
2.4 Ipsen Biopharmaceuticals, Inc
2.4.1 Ipsen Biopharmaceuticals, Inc Details
2.4.2 Ipsen Biopharmaceuticals, Inc Major Business
2.4.3 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Product and Services
2.4.4 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ipsen Biopharmaceuticals, Inc Recent Developments/Updates
2.5 Sun Pharmaceutical Industries Ltd
2.5.1 Sun Pharmaceutical Industries Ltd Details
2.5.2 Sun Pharmaceutical Industries Ltd Major Business
2.5.3 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Product and Services
2.5.4 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
2.6 Amgen Inc.
2.6.1 Amgen Inc. Details
2.6.2 Amgen Inc. Major Business
2.6.3 Amgen Inc. Carcinoid Tumor Syndrome Treatment Product and Services
2.6.4 Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amgen Inc. Recent Developments/Updates
2.7 Entrinsic Health Solutions, Inc.
2.7.1 Entrinsic Health Solutions, Inc. Details
2.7.2 Entrinsic Health Solutions, Inc. Major Business
2.7.3 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Product and Services
2.7.4 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Entrinsic Health Solutions, Inc. Recent Developments/Updates
2.8 Endo Pharmaceuticals Inc.
2.8.1 Endo Pharmaceuticals Inc. Details
2.8.2 Endo Pharmaceuticals Inc. Major Business
2.8.3 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Product and Services
2.8.4 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Endo Pharmaceuticals Inc. Recent Developments/Updates
2.9 Sirtex SIR-Spheres Pty Ltd
2.9.1 Sirtex SIR-Spheres Pty Ltd Details
2.9.2 Sirtex SIR-Spheres Pty Ltd Major Business
2.9.3 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Product and Services
2.9.4 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sirtex SIR-Spheres Pty Ltd Recent Developments/Updates
2.10 BTG International Ltd
2.10.1 BTG International Ltd Details
2.10.2 BTG International Ltd Major Business
2.10.3 BTG International Ltd Carcinoid Tumor Syndrome Treatment Product and Services
2.10.4 BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 BTG International Ltd Recent Developments/Updates
3 Competitive Environment: Carcinoid Tumor Syndrome Treatment by Manufacturer
3.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Carcinoid Tumor Syndrome Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Carcinoid Tumor Syndrome Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Carcinoid Tumor Syndrome Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Carcinoid Tumor Syndrome Treatment Manufacturer Market Share in 2022
3.5 Carcinoid Tumor Syndrome Treatment Market: Overall Company Footprint Analysis
3.5.1 Carcinoid Tumor Syndrome Treatment Market: Region Footprint
3.5.2 Carcinoid Tumor Syndrome Treatment Market: Company Product Type Footprint
3.5.3 Carcinoid Tumor Syndrome Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Carcinoid Tumor Syndrome Treatment Market Size by Region
4.1.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Region (2018-2029)
4.2 North America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
4.3 Europe Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
4.5 South America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
5.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type (2018-2029)
5.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
6.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application (2018-2029)
6.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
7.2 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
7.3 North America Carcinoid Tumor Syndrome Treatment Market Size by Country
7.3.1 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Carcinoid Tumor Syndrome Treatment Market Size by Country
8.3.1 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Carcinoid Tumor Syndrome Treatment Market Size by Region
9.3.1 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
10.2 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
10.3 South America Carcinoid Tumor Syndrome Treatment Market Size by Country
10.3.1 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Carcinoid Tumor Syndrome Treatment Market Size by Country
11.3.1 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Carcinoid Tumor Syndrome Treatment Market Drivers
12.2 Carcinoid Tumor Syndrome Treatment Market Restraints
12.3 Carcinoid Tumor Syndrome Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Carcinoid Tumor Syndrome Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Carcinoid Tumor Syndrome Treatment
13.3 Carcinoid Tumor Syndrome Treatment Production Process
13.4 Carcinoid Tumor Syndrome Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Carcinoid Tumor Syndrome Treatment Typical Distributors
14.3 Carcinoid Tumor Syndrome Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Carcinoid Tumor Syndrome Treatment Product and Services
Table 6. Novartis AG Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceutical Industries Ltd. Major Business
Table 10. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Product and Services
Table 11. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 13. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 14. Mylan N.V. Major Business
Table 15. Mylan N.V. Carcinoid Tumor Syndrome Treatment Product and Services
Table 16. Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mylan N.V. Recent Developments/Updates
Table 18. Ipsen Biopharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 19. Ipsen Biopharmaceuticals, Inc Major Business
Table 20. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Product and Services
Table 21. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ipsen Biopharmaceuticals, Inc Recent Developments/Updates
Table 23. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Industries Ltd Major Business
Table 25. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Product and Services
Table 26. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 28. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Amgen Inc. Major Business
Table 30. Amgen Inc. Carcinoid Tumor Syndrome Treatment Product and Services
Table 31. Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amgen Inc. Recent Developments/Updates
Table 33. Entrinsic Health Solutions, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Entrinsic Health Solutions, Inc. Major Business
Table 35. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Product and Services
Table 36. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Entrinsic Health Solutions, Inc. Recent Developments/Updates
Table 38. Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Endo Pharmaceuticals Inc. Major Business
Table 40. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Product and Services
Table 41. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Endo Pharmaceuticals Inc. Recent Developments/Updates
Table 43. Sirtex SIR-Spheres Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Sirtex SIR-Spheres Pty Ltd Major Business
Table 45. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Product and Services
Table 46. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sirtex SIR-Spheres Pty Ltd Recent Developments/Updates
Table 48. BTG International Ltd Basic Information, Manufacturing Base and Competitors
Table 49. BTG International Ltd Major Business
Table 50. BTG International Ltd Carcinoid Tumor Syndrome Treatment Product and Services
Table 51. BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. BTG International Ltd Recent Developments/Updates
Table 53. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Carcinoid Tumor Syndrome Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Carcinoid Tumor Syndrome Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Carcinoid Tumor Syndrome Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Carcinoid Tumor Syndrome Treatment Production Site of Key Manufacturer
Table 58. Carcinoid Tumor Syndrome Treatment Market: Company Product Type Footprint
Table 59. Carcinoid Tumor Syndrome Treatment Market: Company Product Application Footprint
Table 60. Carcinoid Tumor Syndrome Treatment New Market Entrants and Barriers to Market Entry
Table 61. Carcinoid Tumor Syndrome Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Carcinoid Tumor Syndrome Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Carcinoid Tumor Syndrome Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Carcinoid Tumor Syndrome Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Carcinoid Tumor Syndrome Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Carcinoid Tumor Syndrome Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Carcinoid Tumor Syndrome Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Carcinoid Tumor Syndrome Treatment Raw Material
Table 121. Key Manufacturers of Carcinoid Tumor Syndrome Treatment Raw Materials
Table 122. Carcinoid Tumor Syndrome Treatment Typical Distributors
Table 123. Carcinoid Tumor Syndrome Treatment Typical Customers
List of Figures
Figure 1. Carcinoid Tumor Syndrome Treatment Picture
Figure 2. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Type in 2022
Figure 4. Chemotherapy Examples
Figure 5. Biological Therapy Examples
Figure 6. Radio Therapy Examples
Figure 7. Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Home Examples
Figure 12. Global Carcinoid Tumor Syndrome Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Carcinoid Tumor Syndrome Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Carcinoid Tumor Syndrome Treatment Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Carcinoid Tumor Syndrome Treatment Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Carcinoid Tumor Syndrome Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Carcinoid Tumor Syndrome Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Carcinoid Tumor Syndrome Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Carcinoid Tumor Syndrome Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Carcinoid Tumor Syndrome Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 54. China Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Carcinoid Tumor Syndrome Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Carcinoid Tumor Syndrome Treatment Market Drivers
Figure 75. Carcinoid Tumor Syndrome Treatment Market Restraints
Figure 76. Carcinoid Tumor Syndrome Treatment Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Carcinoid Tumor Syndrome Treatment in 2022
Figure 79. Manufacturing Process Analysis of Carcinoid Tumor Syndrome Treatment
Figure 80. Carcinoid Tumor Syndrome Treatment Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source